PHARMAVRAI
Absorbed by Pharmacie Elise de WaeleOverview
Official details
Source: KBO- Status
- Absorbed by Pharmacie Elise de Waele merger by absorption, February 2023
- Activity
- “La société aura pour objet de faire pour son compte ou pour le compte…” (deed in French)From the articles, 4 activitiesNo NACE code in the KBO yet
- Joint committee
- 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2022
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Board and ownership
Board
- Pharmacie Elise de Waele SRLDirector
Shareholders
- PHARMAVRAI100%· score 942022 annual accounts of PHARMAVRAI
Financial position
No score
Annual accounts 2022
- Gross margin
- €114,957
- ▼ 24.0%
- Turnover
- ≈ €290,000
- estimated
- Profit
- €69,226
- ▼ 42.7%
- Equity
- €188,803
- ▲ 57.9%
- Total assets
- €548,228
- ▲ 11.6%
- Employees on 31-12-2022
- 1
Key points
- Equity rose in 2022from €119,578 to €188,803 ▲ 57.9% View
Recent changes
- · Gazette deed Merger: absorbed by Pharmacie Elise De WaelePharmacie Elise De Waele holds all the shares
- · Gazette deed Merger proposal: to be absorbed by Pharmacie Elise de WaelePharmacie Elise de Waele holds all the shares
Key facts about PHARMAVRAI
- What is the company number of PHARMAVRAI?
- The company number of PHARMAVRAI is 0413.539.308. The VAT number is the same number with BE in front: BE 0413.539.308.
- What is the legal form of PHARMAVRAI?
- The legal form of PHARMAVRAI is SPRL.
- Is PHARMAVRAI still active?
- No. PHARMAVRAI is inactive in the KBO register.Company details
- How many employees did PHARMAVRAI have?
- PHARMAVRAI had an average of 0.1 full-time equivalents in financial year 2022, according to the filed annual accounts.Financials
- Which joint committee does PHARMAVRAI fall under?
- In its 2022 annual accounts, PHARMAVRAI states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
- What is the turnover of PHARMAVRAI?
- The turnover in financial year 2022 is ≈ €290,000. This figure is estimated from the gross margin of €114,957 and 1,647 comparable companies of the same size. It probably lies between €180,000 and €550,000. It is a rough estimate.
- Is PHARMAVRAI profitable?
- In financial year 2022, PHARMAVRAI made a profit of €69,226.
- Where can I find the annual accounts of PHARMAVRAI?
- PHARMAVRAI filed 46 annual accounts with the National Bank of Belgium, the latest for financial year 2022.